Tanabe Pharma

Company snapshot

We have been providing patients with medicines and treatments around the world for over 340 years since Tanabe Seiyaku Co., Ltd. (originally TANABEYA Gohei), the forerunner of our company, was established in 1678 in Osaka, as a family business to produce and sell its proprietary TANABEYA Infusing Medicine, earning the trust of healthcare professionals, patients, their families, and other stakehold

• 4 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Tanabe Pharma. Not investment advice.

• What is Tanabe Pharma?

  Tanabe Pharma is a pharma organization headquartered in Osaka, JP. Primary therapeutic focus areas include Renal Impairment, Osteoarthritis, Knee / Osteoarthritis, Hip. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from publi

• Is Tanabe Pharma publicly traded?

  Tanabe Pharma appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Tanabe Pharma develop or market?

  We link 1 drug profile(s) where Tanabe Pharma is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/mitsubishi-tanabe-pharma-gmbh#company-drugs.

• What are the latest developments for Tanabe Pharma?

  In the last 12 months our linked public records show 4 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Tanabe Pharma focus on?

  Tanabe Pharma focuses on Renal Impairment, Osteoarthritis, Knee / Osteoarthritis, Hip based on our analysis of their pipeline programs and drug development activities.